openPR Logo
Press release

Lower-Limb Spasticity Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight |Ipsen, Allergan, Merz Pharmaceuticals GmbH, Allergan, GlaxoSmithKline

03-20-2025 07:27 AM CET | Health & Medicine

Press release from: DelveInsight Business Research LLP

Lower-Limb Spasticity Market

Lower-Limb Spasticity Market

DelveInsight's "Lower-Limb Spasticity Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Lower-Limb Spasticity, historical and forecasted epidemiology as well as the Lower-Limb Spasticity market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Discover which therapies are expected to grab the Lower-Limb Spasticity Market Share @ Lower-Limb Spasticity Market Outlook- https://www.delveinsight.com/sample-request/lower-limb-spasticity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Key Takeaways from the Lower-Limb Spasticity Market Report
• In February 2025, Merz Pharmaceuticals GmbH announced a study is to determine whether a single treatment with administration of 400 Units NT 201 (botulinum toxin) is superior to placebo (no medicine) for the treatment of lower limb spasticity caused by stroke or traumatic brain injury (Main Period). Participants will be assigned to the treatment groups by chance and neither the participants nor the research staff who interact with them will know the allocation.
• In February 2025, Ipsen organized a clinical study is to assess whether AbobotulinumtoxinA (Dysport®) injections in upper and lower limbs accompanied with a personal exercise plan called "Guided Self-rehabilitation Contract" (GSC) can improve voluntary movements in subjects with hemiparesis.
• The increase in Lower-Limb Spasticity Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Lower-Limb Spasticity Market is anticipated to witness growth at a considerable CAGR.
• The leading Lower-Limb Spasticity Companies such as Ipsen, Allergan, Merz Pharmaceuticals GmbH, Allergan, GlaxoSmithKline, and others.
• Promising Lower-Limb Spasticity Pipeline Therapies such as Botox®, Xeomin, IncobotulinumtoxinA, NT 201, GSK1358820, and others.

Stay ahead in the Lower-Limb Spasticity Therapeutics Market with DelveInsight's Strategic Report @ Lower-Limb Spasticity Market Outlook- https://www.delveinsight.com/sample-request/lower-limb-spasticity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lower-Limb Spasticity Epidemiology Segmentation in the 7MM
The epidemiology section of Lower-Limb Spasticity offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.

Download the report to understand which factors are driving Lower-Limb Spasticity Epidemiology trends @ Lower-Limb Spasticity Prevalence- https://www.delveinsight.com/sample-request/lower-limb-spasticity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lower-Limb Spasticity Drugs Market
The Lower-Limb Spasticity Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Lower-Limb Spasticity signaling in Lower-Limb Spasticity are likely to uncover new therapeutic targets and further expand treatment options for patients.

Lower-Limb Spasticity Treatment Market Landscape
The Lower-Limb Spasticity treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Lower-Limb Spasticity has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.

To learn more about Lower-Limb Spasticity treatment guidelines, visit @ Lower-Limb Spasticity Treatment Market Landscape- https://www.delveinsight.com/sample-request/lower-limb-spasticity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Lower-Limb Spasticity Market Outlook
The report's outlook on the Lower-Limb Spasticity market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Lower-Limb Spasticity therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Lower-Limb Spasticity drug and late-stage pipeline therapy.

Lower-Limb Spasticity Drugs Uptake
The drug chapter of the Lower-Limb Spasticity report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Lower-Limb Spasticity.

Major Lower-Limb Spasticity Companies
Ipsen, Allergan, Merz Pharmaceuticals GmbH, Allergan, GlaxoSmithKline, and others.

Learn more about the FDA-approved drugs for Lower-Limb Spasticity @ Drugs for Lower-Limb Spasticity Treatment- https://www.delveinsight.com/sample-request/lower-limb-spasticity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Scope of the Lower-Limb Spasticity Market Report
• Coverage- 7MM
• Study Period- 2019-2032
• Lower-Limb Spasticity Companies- Ipsen, Allergan, Merz Pharmaceuticals GmbH, Allergan, GlaxoSmithKline, and others.
• Lower-Limb Spasticity Pipeline Therapies- Botox®, Xeomin, IncobotulinumtoxinA, NT 201, GSK1358820, and others.
• Lower-Limb Spasticity Market Dynamics: Lower-Limb Spasticity Market Drivers and Barriers
• Lower-Limb Spasticity Market Access and Reimbursement, Unmet Needs and Future Perspectives

Discover more about Lower-Limb Spasticity Drugs in development @ Lower-Limb Spasticity Clinical Trials Assessment - https://www.delveinsight.com/sample-request/lower-limb-spasticity-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr

Table of Content
1. Key Insights
2. Lower-Limb Spasticity Executive Summary
3. Competitive Intelligence Analysis for Lower-Limb Spasticity
4. Lower-Limb Spasticity: Market Overview at a Glance
5. Lower-Limb Spasticity: Disease Background and Overview
6. Patient Journey
7. Lower-Limb Spasticity Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Lower-Limb Spasticity Unmet Needs
10. Key Endpoints of Lower-Limb Spasticity Treatment
11. Lower-Limb Spasticity Marketed Products
12. Lower-Limb Spasticity Emerging Therapies
13. Lower-Limb Spasticity: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Lower-Limb Spasticity Market Outlook
16. Access and Reimbursement Overview of Lower-Limb Spasticity
17. KOL Views
18. Lower-Limb Spasticity Market Drivers
19. Lower-Limb Spasticity Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight

List of Top Selling Market Research Reports in 2025

Biopsy devices market- https://www.delveinsight.com/report-store/biopsy-devices-market
Diabetic wound market - https://www.delveinsight.com/report-store/diabetic-wounds-market
Joint reconstruction devices market- https://www.delveinsight.com/report-store/joint-reconstruction-devices-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
Spinal implants market- https://www.delveinsight.com/report-store/spinal-implants-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Cystic fibrosis market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Heart failure market- https://www.delveinsight.com/report-store/congestive-heart-failure-market
NK Cell therapy market- https://www.delveinsight.com/report-store/nk-cell-therapy-market
Positive airway pressure device market - https://www.delveinsight.com/report-store/positive-airway-pressure-device-market
Stem cell market- https://www.delveinsight.com/report-store/stem-cell-market
Surgical sealant market- https://www.delveinsight.com/report-store/surgical-sealant-tissue-patch-market
Thyroid cancer market- https://www.delveinsight.com/report-store/thyroid-cancer-market
Urinary catheters market- https://www.delveinsight.com/report-store/urinary-catheters-market
Intraocular lens market- https://www.delveinsight.com/report-store/intraocular-lens-market
Uterine fibroids market- https://www.delveinsight.com/report-store/uterine-leiomyoma-uterine-fibroids-market
Attention deficit hyperactivity disorder adhd market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Lice infestations market- https://www.delveinsight.com/report-store/lice-infestations-market
Lymphoedema market- https://www.delveinsight.com/report-store/lymphoedema-market
Dyspepsia market- https://www.delveinsight.com/report-store/functional-dyspepsia-pipeline-insight
Antibody drug conjugate market- https://www.delveinsight.com/report-store/antibody-drug-conjugate-adc-market
Surgical mask & respirator market- https://www.delveinsight.com/report-store/surgical-mask-respirator-market
Bone growth stimulator market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market

About Us

DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.

Contact Us
Yash Bhardwaj
info@delveinsight.com
https://www.delveinsight.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lower-Limb Spasticity Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight |Ipsen, Allergan, Merz Pharmaceuticals GmbH, Allergan, GlaxoSmithKline here

News-ID: 3925967 • Views:

More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight and stay ahead
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore the comprehensive insights by DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsight
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market

All 5 Releases


More Releases for Spasticity

Muscle Spasticity Market Emerging Trends and Growth Prospects 2034
Introduction Muscle spasticity is a condition characterized by involuntary muscle stiffness, spasms, and increased tone, often resulting from neurological disorders such as multiple sclerosis, cerebral palsy, stroke, or traumatic brain and spinal cord injuries. It significantly impacts mobility and quality of life, making effective management essential. With the rising incidence of neurological diseases and advancements in physiotherapy, drug therapies, and medical devices, the global muscle spasticity market is witnessing steady expansion. According
Comprehensive 2025 Muscle Spasticity Market Overview: Trends, Forecasts, and Gro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Muscle Spasticity Market Through 2025? In recent times, there has been a robust growth in the market size of muscle spasticity. The market, which is projected to increase from $4.19 billion in 2024 to $4.57 billion in 2025, has a compound annual
Spasticity Drugs Market Segments, Growth and Trends by Forecast by 2031
The report is segmented By Drug Type (Baclofen, Botulinum Toxin, Diazepam, Tizanidine, Dantrolene Sodium, and Others), Route of Administration (Oral, Intramuscular, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments. Get Sample Copy -https://www.theinsightpartners.com/sample/TIPRE00040811/?utm_source=OpenPR&utm_medium=10831 Major Companies operating in the Spasticity Drugs Market are: Ipsen Pharma Allergan Acorda Therapeutics,
Spasticity Drugs Top Companies Regional and Data Analysis to 2031
The Spasticity Drugs Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00040811/?utm_source=OpenPR&utm_medium=10129 Major Companies operating in the Spasticity Drugs Market are: • Ipsen Pharma • Allergan • Acorda Therapeutics, Inc. • Merz Pharma • Teva Pharmaceutical Industries Ltd. • Novartis AG • Sun Pharmaceutical Industries Ltd. • Beximco Pharmaceuticals Ltd. • Johnson & Johnson Private Limited • Zydus Cadila Contact Us: If you have any queries about this report or if
Spasticity Treatment Market Expecting Huge Demand in Upcoming Years
The Global Spasticity Treatment Market size is estimated at $5.7 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 4.9% to reach $8.8 Billion by 2034. Download now The latest study released on the Global Spasticity Treatment Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Spasticity Treatment market study covers significant research data and proofs to be a handy resource
Muscle Spasticity Market Growth, Research Report, Analysis & Trends 2023-2033
Muscle Spasticity Market Report Overview:       Report Attribute Details Base Year 2022 Forecast Years